Global Inhalation and Nasal Drug Delivery Devices Market Growth 2024-2030
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Inhalation and Nasal Drug Delivery Devices Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Inhalation and Nasal Drug Delivery Devices by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Inhalation and Nasal Drug Delivery Devices by Country/Region, 2019, 2023 & 2030 2.2 Inhalation and Nasal Drug Delivery Devices Segment by Type 2.2.1 Metered- dose Inhalers 2.2.2 Dry-powder Inhalers 2.2.3 Nebulizers 2.3 Inhalation and Nasal Drug Delivery Devices Sales by Type 2.3.1 Global Inhalation and Nasal Drug Delivery Devices Sales Market Share by Type (2019-2024) 2.3.2 Global Inhalation and Nasal Drug Delivery Devices Revenue and Market Share by Type (2019-2024) 2.3.3 Global Inhalation and Nasal Drug Delivery Devices Sale Price by Type (2019-2024) 2.4 Inhalation and Nasal Drug Delivery Devices Segment by Application 2.4.1 Asthma 2.4.2 Chronic Obstructive Pulmonary Disease (COPD) 2.4.3 Cystic Fibrosis (CF) 2.4.4 Idiopathic Pulmonary Fibrosis (IPF) 2.4.5 Others 2.5 Inhalation and Nasal Drug Delivery Devices Sales by Application 2.5.1 Global Inhalation and Nasal Drug Delivery Devices Sale Market Share by Application (2019-2024) 2.5.2 Global Inhalation and Nasal Drug Delivery Devices Revenue and Market Share by Application (2019-2024) 2.5.3 Global Inhalation and Nasal Drug Delivery Devices Sale Price by Application (2019-2024) 3 Global by Company 3.1 Global Inhalation and Nasal Drug Delivery Devices Breakdown Data by Company 3.1.1 Global Inhalation and Nasal Drug Delivery Devices Annual Sales by Company (2019-2024) 3.1.2 Global Inhalation and Nasal Drug Delivery Devices Sales Market Share by Company (2019-2024) 3.2 Global Inhalation and Nasal Drug Delivery Devices Annual Revenue by Company (2019-2024) 3.2.1 Global Inhalation and Nasal Drug Delivery Devices Revenue by Company (2019-2024) 3.2.2 Global Inhalation and Nasal Drug Delivery Devices Revenue Market Share by Company (2019-2024) 3.3 Global Inhalation and Nasal Drug Delivery Devices Sale Price by Company 3.4 Key Manufacturers Inhalation and Nasal Drug Delivery Devices Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Inhalation and Nasal Drug Delivery Devices Product Location Distribution 3.4.2 Players Inhalation and Nasal Drug Delivery Devices Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Inhalation and Nasal Drug Delivery Devices by Geographic Region 4.1 World Historic Inhalation and Nasal Drug Delivery Devices Market Size by Geographic Region (2019-2024) 4.1.1 Global Inhalation and Nasal Drug Delivery Devices Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Inhalation and Nasal Drug Delivery Devices Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Inhalation and Nasal Drug Delivery Devices Market Size by Country/Region (2019-2024) 4.2.1 Global Inhalation and Nasal Drug Delivery Devices Annual Sales by Country/Region (2019-2024) 4.2.2 Global Inhalation and Nasal Drug Delivery Devices Annual Revenue by Country/Region (2019-2024) 4.3 Americas Inhalation and Nasal Drug Delivery Devices Sales Growth 4.4 APAC Inhalation and Nasal Drug Delivery Devices Sales Growth 4.5 Europe Inhalation and Nasal Drug Delivery Devices Sales Growth 4.6 Middle East & Africa Inhalation and Nasal Drug Delivery Devices Sales Growth 5 Americas 5.1 Americas Inhalation and Nasal Drug Delivery Devices Sales by Country 5.1.1 Americas Inhalation and Nasal Drug Delivery Devices Sales by Country (2019-2024) 5.1.2 Americas Inhalation and Nasal Drug Delivery Devices Revenue by Country (2019-2024) 5.2 Americas Inhalation and Nasal Drug Delivery Devices Sales by Type (2019-2024) 5.3 Americas Inhalation and Nasal Drug Delivery Devices Sales by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Inhalation and Nasal Drug Delivery Devices Sales by Region 6.1.1 APAC Inhalation and Nasal Drug Delivery Devices Sales by Region (2019-2024) 6.1.2 APAC Inhalation and Nasal Drug Delivery Devices Revenue by Region (2019-2024) 6.2 APAC Inhalation and Nasal Drug Delivery Devices Sales by Type (2019-2024) 6.3 APAC Inhalation and Nasal Drug Delivery Devices Sales by Application (2019-2024) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Inhalation and Nasal Drug Delivery Devices by Country 7.1.1 Europe Inhalation and Nasal Drug Delivery Devices Sales by Country (2019-2024) 7.1.2 Europe Inhalation and Nasal Drug Delivery Devices Revenue by Country (2019-2024) 7.2 Europe Inhalation and Nasal Drug Delivery Devices Sales by Type (2019-2024) 7.3 Europe Inhalation and Nasal Drug Delivery Devices Sales by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Inhalation and Nasal Drug Delivery Devices by Country 8.1.1 Middle East & Africa Inhalation and Nasal Drug Delivery Devices Sales by Country (2019-2024) 8.1.2 Middle East & Africa Inhalation and Nasal Drug Delivery Devices Revenue by Country (2019-2024) 8.2 Middle East & Africa Inhalation and Nasal Drug Delivery Devices Sales by Type (2019-2024) 8.3 Middle East & Africa Inhalation and Nasal Drug Delivery Devices Sales by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Inhalation and Nasal Drug Delivery Devices 10.3 Manufacturing Process Analysis of Inhalation and Nasal Drug Delivery Devices 10.4 Industry Chain Structure of Inhalation and Nasal Drug Delivery Devices 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Inhalation and Nasal Drug Delivery Devices Distributors 11.3 Inhalation and Nasal Drug Delivery Devices Customer 12 World Forecast Review for Inhalation and Nasal Drug Delivery Devices by Geographic Region 12.1 Global Inhalation and Nasal Drug Delivery Devices Market Size Forecast by Region 12.1.1 Global Inhalation and Nasal Drug Delivery Devices Forecast by Region (2025-2030) 12.1.2 Global Inhalation and Nasal Drug Delivery Devices Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country (2025-2030) 12.3 APAC Forecast by Region (2025-2030) 12.4 Europe Forecast by Country (2025-2030) 12.5 Middle East & Africa Forecast by Country (2025-2030) 12.6 Global Inhalation and Nasal Drug Delivery Devices Forecast by Type (2025-2030) 12.7 Global Inhalation and Nasal Drug Delivery Devices Forecast by Application (2025-2030) 13 Key Players Analysis 13.1 GlaxoSmithKline (GSK) 13.1.1 GlaxoSmithKline (GSK) Company Information 13.1.2 GlaxoSmithKline (GSK) Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications 13.1.3 GlaxoSmithKline (GSK) Inhalation and Nasal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 GlaxoSmithKline (GSK) Main Business Overview 13.1.5 GlaxoSmithKline (GSK) Latest Developments 13.2 AstraZeneca 13.2.1 AstraZeneca Company Information 13.2.2 AstraZeneca Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications 13.2.3 AstraZeneca Inhalation and Nasal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 AstraZeneca Main Business Overview 13.2.5 AstraZeneca Latest Developments 13.3 Boehringer Ingelheim 13.3.1 Boehringer Ingelheim Company Information 13.3.2 Boehringer Ingelheim Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications 13.3.3 Boehringer Ingelheim Inhalation and Nasal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 Boehringer Ingelheim Main Business Overview 13.3.5 Boehringer Ingelheim Latest Developments 13.4 Viatris 13.4.1 Viatris Company Information 13.4.2 Viatris Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications 13.4.3 Viatris Inhalation and Nasal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 Viatris Main Business Overview 13.4.5 Viatris Latest Developments 13.5 Merck 13.5.1 Merck Company Information 13.5.2 Merck Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications 13.5.3 Merck Inhalation and Nasal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 Merck Main Business Overview 13.5.5 Merck Latest Developments 13.6 Novartis 13.6.1 Novartis Company Information 13.6.2 Novartis Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications 13.6.3 Novartis Inhalation and Nasal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.6.4 Novartis Main Business Overview 13.6.5 Novartis Latest Developments 13.7 AptarGroup 13.7.1 AptarGroup Company Information 13.7.2 AptarGroup Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications 13.7.3 AptarGroup Inhalation and Nasal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.7.4 AptarGroup Main Business Overview 13.7.5 AptarGroup Latest Developments 13.8 Chiesi Farmaceutici 13.8.1 Chiesi Farmaceutici Company Information 13.8.2 Chiesi Farmaceutici Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications 13.8.3 Chiesi Farmaceutici Inhalation and Nasal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.8.4 Chiesi Farmaceutici Main Business Overview 13.8.5 Chiesi Farmaceutici Latest Developments 13.9 Koninklijke Philips 13.9.1 Koninklijke Philips Company Information 13.9.2 Koninklijke Philips Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications 13.9.3 Koninklijke Philips Inhalation and Nasal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.9.4 Koninklijke Philips Main Business Overview 13.9.5 Koninklijke Philips Latest Developments 13.10 Teva Pharmaceutical Industries 13.10.1 Teva Pharmaceutical Industries Company Information 13.10.2 Teva Pharmaceutical Industries Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications 13.10.3 Teva Pharmaceutical Industries Inhalation and Nasal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.10.4 Teva Pharmaceutical Industries Main Business Overview 13.10.5 Teva Pharmaceutical Industries Latest Developments 13.11 Monaghan Medical 13.11.1 Monaghan Medical Company Information 13.11.2 Monaghan Medical Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications 13.11.3 Monaghan Medical Inhalation and Nasal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.11.4 Monaghan Medical Main Business Overview 13.11.5 Monaghan Medical Latest Developments 13.12 OMRON 13.12.1 OMRON Company Information 13.12.2 OMRON Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications 13.12.3 OMRON Inhalation and Nasal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.12.4 OMRON Main Business Overview 13.12.5 OMRON Latest Developments 13.13 PARI International 13.13.1 PARI International Company Information 13.13.2 PARI International Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications 13.13.3 PARI International Inhalation and Nasal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.13.4 PARI International Main Business Overview 13.13.5 PARI International Latest Developments 13.14 Vectura 13.14.1 Vectura Company Information 13.14.2 Vectura Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications 13.14.3 Vectura Inhalation and Nasal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.14.4 Vectura Main Business Overview 13.14.5 Vectura Latest Developments 13.15 H&T Presspart 13.15.1 H&T Presspart Company Information 13.15.2 H&T Presspart Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications 13.15.3 H&T Presspart Inhalation and Nasal Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.15.4 H&T Presspart Main Business Overview 13.15.5 H&T Presspart Latest Developments 14 Research Findings and Conclusion
List of Tables Table 1. Inhalation and Nasal Drug Delivery Devices Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions) Table 2. Inhalation and Nasal Drug Delivery Devices Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions) Table 3. Major Players of Metered- dose Inhalers Table 4. Major Players of Dry-powder Inhalers Table 5. Major Players of Nebulizers Table 6. Global Inhalation and Nasal Drug Delivery Devices Sales by Type (2019-2024) & (K Units) Table 7. Global Inhalation and Nasal Drug Delivery Devices Sales Market Share by Type (2019-2024) Table 8. Global Inhalation and Nasal Drug Delivery Devices Revenue by Type (2019-2024) & ($ million) Table 9. Global Inhalation and Nasal Drug Delivery Devices Revenue Market Share by Type (2019-2024) Table 10. Global Inhalation and Nasal Drug Delivery Devices Sale Price by Type (2019-2024) & (US$/Unit) Table 11. Global Inhalation and Nasal Drug Delivery Devices Sale by Application (2019-2024) & (K Units) Table 12. Global Inhalation and Nasal Drug Delivery Devices Sale Market Share by Application (2019-2024) Table 13. Global Inhalation and Nasal Drug Delivery Devices Revenue by Application (2019-2024) & ($ million) Table 14. Global Inhalation and Nasal Drug Delivery Devices Revenue Market Share by Application (2019-2024) Table 15. Global Inhalation and Nasal Drug Delivery Devices Sale Price by Application (2019-2024) & (US$/Unit) Table 16. Global Inhalation and Nasal Drug Delivery Devices Sales by Company (2019-2024) & (K Units) Table 17. Global Inhalation and Nasal Drug Delivery Devices Sales Market Share by Company (2019-2024) Table 18. Global Inhalation and Nasal Drug Delivery Devices Revenue by Company (2019-2024) & ($ millions) Table 19. Global Inhalation and Nasal Drug Delivery Devices Revenue Market Share by Company (2019-2024) Table 20. Global Inhalation and Nasal Drug Delivery Devices Sale Price by Company (2019-2024) & (US$/Unit) Table 21. Key Manufacturers Inhalation and Nasal Drug Delivery Devices Producing Area Distribution and Sales Area Table 22. Players Inhalation and Nasal Drug Delivery Devices Products Offered Table 23. Inhalation and Nasal Drug Delivery Devices Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) Table 24. New Products and Potential Entrants Table 25. Market M&A Activity & Strategy Table 26. Global Inhalation and Nasal Drug Delivery Devices Sales by Geographic Region (2019-2024) & (K Units) Table 27. Global Inhalation and Nasal Drug Delivery Devices Sales Market Share Geographic Region (2019-2024) Table 28. Global Inhalation and Nasal Drug Delivery Devices Revenue by Geographic Region (2019-2024) & ($ millions) Table 29. Global Inhalation and Nasal Drug Delivery Devices Revenue Market Share by Geographic Region (2019-2024) Table 30. Global Inhalation and Nasal Drug Delivery Devices Sales by Country/Region (2019-2024) & (K Units) Table 31. Global Inhalation and Nasal Drug Delivery Devices Sales Market Share by Country/Region (2019-2024) Table 32. Global Inhalation and Nasal Drug Delivery Devices Revenue by Country/Region (2019-2024) & ($ millions) Table 33. Global Inhalation and Nasal Drug Delivery Devices Revenue Market Share by Country/Region (2019-2024) Table 34. Americas Inhalation and Nasal Drug Delivery Devices Sales by Country (2019-2024) & (K Units) Table 35. Americas Inhalation and Nasal Drug Delivery Devices Sales Market Share by Country (2019-2024) Table 36. Americas Inhalation and Nasal Drug Delivery Devices Revenue by Country (2019-2024) & ($ millions) Table 37. Americas Inhalation and Nasal Drug Delivery Devices Sales by Type (2019-2024) & (K Units) Table 38. Americas Inhalation and Nasal Drug Delivery Devices Sales by Application (2019-2024) & (K Units) Table 39. APAC Inhalation and Nasal Drug Delivery Devices Sales by Region (2019-2024) & (K Units) Table 40. APAC Inhalation and Nasal Drug Delivery Devices Sales Market Share by Region (2019-2024) Table 41. APAC Inhalation and Nasal Drug Delivery Devices Revenue by Region (2019-2024) & ($ millions) Table 42. APAC Inhalation and Nasal Drug Delivery Devices Sales by Type (2019-2024) & (K Units) Table 43. APAC Inhalation and Nasal Drug Delivery Devices Sales by Application (2019-2024) & (K Units) Table 44. Europe Inhalation and Nasal Drug Delivery Devices Sales by Country (2019-2024) & (K Units) Table 45. Europe Inhalation and Nasal Drug Delivery Devices Revenue by Country (2019-2024) & ($ millions) Table 46. Europe Inhalation and Nasal Drug Delivery Devices Sales by Type (2019-2024) & (K Units) Table 47. Europe Inhalation and Nasal Drug Delivery Devices Sales by Application (2019-2024) & (K Units) Table 48. Middle East & Africa Inhalation and Nasal Drug Delivery Devices Sales by Country (2019-2024) & (K Units) Table 49. Middle East & Africa Inhalation and Nasal Drug Delivery Devices Revenue Market Share by Country (2019-2024) Table 50. Middle East & Africa Inhalation and Nasal Drug Delivery Devices Sales by Type (2019-2024) & (K Units) Table 51. Middle East & Africa Inhalation and Nasal Drug Delivery Devices Sales by Application (2019-2024) & (K Units) Table 52. Key Market Drivers & Growth Opportunities of Inhalation and Nasal Drug Delivery Devices Table 53. Key Market Challenges & Risks of Inhalation and Nasal Drug Delivery Devices Table 54. Key Industry Trends of Inhalation and Nasal Drug Delivery Devices Table 55. Inhalation and Nasal Drug Delivery Devices Raw Material Table 56. Key Suppliers of Raw Materials Table 57. Inhalation and Nasal Drug Delivery Devices Distributors List Table 58. Inhalation and Nasal Drug Delivery Devices Customer List Table 59. Global Inhalation and Nasal Drug Delivery Devices Sales Forecast by Region (2025-2030) & (K Units) Table 60. Global Inhalation and Nasal Drug Delivery Devices Revenue Forecast by Region (2025-2030) & ($ millions) Table 61. Americas Inhalation and Nasal Drug Delivery Devices Sales Forecast by Country (2025-2030) & (K Units) Table 62. Americas Inhalation and Nasal Drug Delivery Devices Annual Revenue Forecast by Country (2025-2030) & ($ millions) Table 63. APAC Inhalation and Nasal Drug Delivery Devices Sales Forecast by Region (2025-2030) & (K Units) Table 64. APAC Inhalation and Nasal Drug Delivery Devices Annual Revenue Forecast by Region (2025-2030) & ($ millions) Table 65. Europe Inhalation and Nasal Drug Delivery Devices Sales Forecast by Country (2025-2030) & (K Units) Table 66. Europe Inhalation and Nasal Drug Delivery Devices Revenue Forecast by Country (2025-2030) & ($ millions) Table 67. Middle East & Africa Inhalation and Nasal Drug Delivery Devices Sales Forecast by Country (2025-2030) & (K Units) Table 68. Middle East & Africa Inhalation and Nasal Drug Delivery Devices Revenue Forecast by Country (2025-2030) & ($ millions) Table 69. Global Inhalation and Nasal Drug Delivery Devices Sales Forecast by Type (2025-2030) & (K Units) Table 70. Global Inhalation and Nasal Drug Delivery Devices Revenue Forecast by Type (2025-2030) & ($ millions) Table 71. Global Inhalation and Nasal Drug Delivery Devices Sales Forecast by Application (2025-2030) & (K Units) Table 72. Global Inhalation and Nasal Drug Delivery Devices Revenue Forecast by Application (2025-2030) & ($ millions) Table 73. GlaxoSmithKline (GSK) Basic Information, Inhalation and Nasal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors Table 74. GlaxoSmithKline (GSK) Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications Table 75. GlaxoSmithKline (GSK) Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 76. GlaxoSmithKline (GSK) Main Business Table 77. GlaxoSmithKline (GSK) Latest Developments Table 78. AstraZeneca Basic Information, Inhalation and Nasal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors Table 79. AstraZeneca Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications Table 80. AstraZeneca Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 81. AstraZeneca Main Business Table 82. AstraZeneca Latest Developments Table 83. Boehringer Ingelheim Basic Information, Inhalation and Nasal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors Table 84. Boehringer Ingelheim Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications Table 85. Boehringer Ingelheim Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 86. Boehringer Ingelheim Main Business Table 87. Boehringer Ingelheim Latest Developments Table 88. Viatris Basic Information, Inhalation and Nasal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors Table 89. Viatris Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications Table 90. Viatris Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 91. Viatris Main Business Table 92. Viatris Latest Developments Table 93. Merck Basic Information, Inhalation and Nasal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors Table 94. Merck Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications Table 95. Merck Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 96. Merck Main Business Table 97. Merck Latest Developments Table 98. Novartis Basic Information, Inhalation and Nasal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors Table 99. Novartis Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications Table 100. Novartis Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 101. Novartis Main Business Table 102. Novartis Latest Developments Table 103. AptarGroup Basic Information, Inhalation and Nasal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors Table 104. AptarGroup Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications Table 105. AptarGroup Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 106. AptarGroup Main Business Table 107. AptarGroup Latest Developments Table 108. Chiesi Farmaceutici Basic Information, Inhalation and Nasal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors Table 109. Chiesi Farmaceutici Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications Table 110. Chiesi Farmaceutici Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 111. Chiesi Farmaceutici Main Business Table 112. Chiesi Farmaceutici Latest Developments Table 113. Koninklijke Philips Basic Information, Inhalation and Nasal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors Table 114. Koninklijke Philips Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications Table 115. Koninklijke Philips Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 116. Koninklijke Philips Main Business Table 117. Koninklijke Philips Latest Developments Table 118. Teva Pharmaceutical Industries Basic Information, Inhalation and Nasal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors Table 119. Teva Pharmaceutical Industries Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications Table 120. Teva Pharmaceutical Industries Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 121. Teva Pharmaceutical Industries Main Business Table 122. Teva Pharmaceutical Industries Latest Developments Table 123. Monaghan Medical Basic Information, Inhalation and Nasal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors Table 124. Monaghan Medical Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications Table 125. Monaghan Medical Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 126. Monaghan Medical Main Business Table 127. Monaghan Medical Latest Developments Table 128. OMRON Basic Information, Inhalation and Nasal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors Table 129. OMRON Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications Table 130. OMRON Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 131. OMRON Main Business Table 132. OMRON Latest Developments Table 133. PARI International Basic Information, Inhalation and Nasal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors Table 134. PARI International Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications Table 135. PARI International Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 136. PARI International Main Business Table 137. PARI International Latest Developments Table 138. Vectura Basic Information, Inhalation and Nasal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors Table 139. Vectura Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications Table 140. Vectura Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 141. Vectura Main Business Table 142. Vectura Latest Developments Table 143. H&T Presspart Basic Information, Inhalation and Nasal Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors Table 144. H&T Presspart Inhalation and Nasal Drug Delivery Devices Product Portfolios and Specifications Table 145. H&T Presspart Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 146. H&T Presspart Main Business Table 147. H&T Presspart Latest Developments List of Figures Figure 1. Picture of Inhalation and Nasal Drug Delivery Devices Figure 2. Inhalation and Nasal Drug Delivery Devices Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Inhalation and Nasal Drug Delivery Devices Sales Growth Rate 2019-2030 (K Units) Figure 7. Global Inhalation and Nasal Drug Delivery Devices Revenue Growth Rate 2019-2030 ($ millions) Figure 8. Inhalation and Nasal Drug Delivery Devices Sales by Geographic Region (2019, 2023 & 2030) & ($ millions) Figure 9. Inhalation and Nasal Drug Delivery Devices Sales Market Share by Country/Region (2023) Figure 10. Inhalation and Nasal Drug Delivery Devices Sales Market Share by Country/Region (2019, 2023 & 2030) Figure 11. Product Picture of Metered- dose Inhalers Figure 12. Product Picture of Dry-powder Inhalers Figure 13. Product Picture of Nebulizers Figure 14. Global Inhalation and Nasal Drug Delivery Devices Sales Market Share by Type in 2023 Figure 15. Global Inhalation and Nasal Drug Delivery Devices Revenue Market Share by Type (2019-2024) Figure 16. Inhalation and Nasal Drug Delivery Devices Consumed in Asthma Figure 17. Global Inhalation and Nasal Drug Delivery Devices Market: Asthma (2019-2024) & (K Units) Figure 18. Inhalation and Nasal Drug Delivery Devices Consumed in Chronic Obstructive Pulmonary Disease (COPD) Figure 19. Global Inhalation and Nasal Drug Delivery Devices Market: Chronic Obstructive Pulmonary Disease (COPD) (2019-2024) & (K Units) Figure 20. Inhalation and Nasal Drug Delivery Devices Consumed in Cystic Fibrosis (CF) Figure 21. Global Inhalation and Nasal Drug Delivery Devices Market: Cystic Fibrosis (CF) (2019-2024) & (K Units) Figure 22. Inhalation and Nasal Drug Delivery Devices Consumed in Idiopathic Pulmonary Fibrosis (IPF) Figure 23. Global Inhalation and Nasal Drug Delivery Devices Market: Idiopathic Pulmonary Fibrosis (IPF) (2019-2024) & (K Units) Figure 24. Inhalation and Nasal Drug Delivery Devices Consumed in Others Figure 25. Global Inhalation and Nasal Drug Delivery Devices Market: Others (2019-2024) & (K Units) Figure 26. Global Inhalation and Nasal Drug Delivery Devices Sale Market Share by Application (2023) Figure 27. Global Inhalation and Nasal Drug Delivery Devices Revenue Market Share by Application in 2023 Figure 28. Inhalation and Nasal Drug Delivery Devices Sales by Company in 2023 (K Units) Figure 29. Global Inhalation and Nasal Drug Delivery Devices Sales Market Share by Company in 2023 Figure 30. Inhalation and Nasal Drug Delivery Devices Revenue by Company in 2023 ($ millions) Figure 31. Global Inhalation and Nasal Drug Delivery Devices Revenue Market Share by Company in 2023 Figure 32. Global Inhalation and Nasal Drug Delivery Devices Sales Market Share by Geographic Region (2019-2024) Figure 33. Global Inhalation and Nasal Drug Delivery Devices Revenue Market Share by Geographic Region in 2023 Figure 34. Americas Inhalation and Nasal Drug Delivery Devices Sales 2019-2024 (K Units) Figure 35. Americas Inhalation and Nasal Drug Delivery Devices Revenue 2019-2024 ($ millions) Figure 36. APAC Inhalation and Nasal Drug Delivery Devices Sales 2019-2024 (K Units) Figure 37. APAC Inhalation and Nasal Drug Delivery Devices Revenue 2019-2024 ($ millions) Figure 38. Europe Inhalation and Nasal Drug Delivery Devices Sales 2019-2024 (K Units) Figure 39. Europe Inhalation and Nasal Drug Delivery Devices Revenue 2019-2024 ($ millions) Figure 40. Middle East & Africa Inhalation and Nasal Drug Delivery Devices Sales 2019-2024 (K Units) Figure 41. Middle East & Africa Inhalation and Nasal Drug Delivery Devices Revenue 2019-2024 ($ millions) Figure 42. Americas Inhalation and Nasal Drug Delivery Devices Sales Market Share by Country in 2023 Figure 43. Americas Inhalation and Nasal Drug Delivery Devices Revenue Market Share by Country (2019-2024) Figure 44. Americas Inhalation and Nasal Drug Delivery Devices Sales Market Share by Type (2019-2024) Figure 45. Americas Inhalation and Nasal Drug Delivery Devices Sales Market Share by Application (2019-2024) Figure 46. United States Inhalation and Nasal Drug Delivery Devices Revenue Growth 2019-2024 ($ millions) Figure 47. Canada Inhalation and Nasal Drug Delivery Devices Revenue Growth 2019-2024 ($ millions) Figure 48. Mexico Inhalation and Nasal Drug Delivery Devices Revenue Growth 2019-2024 ($ millions) Figure 49. Brazil Inhalation and Nasal Drug Delivery Devices Revenue Growth 2019-2024 ($ millions) Figure 50. APAC Inhalation and Nasal Drug Delivery Devices Sales Market Share by Region in 2023 Figure 51. APAC Inhalation and Nasal Drug Delivery Devices Revenue Market Share by Region (2019-2024) Figure 52. APAC Inhalation and Nasal Drug Delivery Devices Sales Market Share by Type (2019-2024) Figure 53. APAC Inhalation and Nasal Drug Delivery Devices Sales Market Share by Application (2019-2024) Figure 54. China Inhalation and Nasal Drug Delivery Devices Revenue Growth 2019-2024 ($ millions) Figure 55. Japan Inhalation and Nasal Drug Delivery Devices Revenue Growth 2019-2024 ($ millions) Figure 56. South Korea Inhalation and Nasal Drug Delivery Devices Revenue Growth 2019-2024 ($ millions) Figure 57. Southeast Asia Inhalation and Nasal Drug Delivery Devices Revenue Growth 2019-2024 ($ millions) Figure 58. India Inhalation and Nasal Drug Delivery Devices Revenue Growth 2019-2024 ($ millions) Figure 59. Australia Inhalation and Nasal Drug Delivery Devices Revenue Growth 2019-2024 ($ millions) Figure 60. China Taiwan Inhalation and Nasal Drug Delivery Devices Revenue Growth 2019-2024 ($ millions) Figure 61. Europe Inhalation and Nasal Drug Delivery Devices Sales Market Share by Country in 2023 Figure 62. Europe Inhalation and Nasal Drug Delivery Devices Revenue Market Share by Country (2019-2024) Figure 63. Europe Inhalation and Nasal Drug Delivery Devices Sales Market Share by Type (2019-2024) Figure 64. Europe Inhalation and Nasal Drug Delivery Devices Sales Market Share by Application (2019-2024) Figure 65. Germany Inhalation and Nasal Drug Delivery Devices Revenue Growth 2019-2024 ($ millions) Figure 66. France Inhalation and Nasal Drug Delivery Devices Revenue Growth 2019-2024 ($ millions) Figure 67. UK Inhalation and Nasal Drug Delivery Devices Revenue Growth 2019-2024 ($ millions) Figure 68. Italy Inhalation and Nasal Drug Delivery Devices Revenue Growth 2019-2024 ($ millions) Figure 69. Russia Inhalation and Nasal Drug Delivery Devices Revenue Growth 2019-2024 ($ millions) Figure 70. Middle East & Africa Inhalation and Nasal Drug Delivery Devices Sales Market Share by Country (2019-2024) Figure 71. Middle East & Africa Inhalation and Nasal Drug Delivery Devices Sales Market Share by Type (2019-2024) Figure 72. Middle East & Africa Inhalation and Nasal Drug Delivery Devices Sales Market Share by Application (2019-2024) Figure 73. Egypt Inhalation and Nasal Drug Delivery Devices Revenue Growth 2019-2024 ($ millions) Figure 74. South Africa Inhalation and Nasal Drug Delivery Devices Revenue Growth 2019-2024 ($ millions) Figure 75. Israel Inhalation and Nasal Drug Delivery Devices Revenue Growth 2019-2024 ($ millions) Figure 76. Turkey Inhalation and Nasal Drug Delivery Devices Revenue Growth 2019-2024 ($ millions) Figure 77. GCC Countries Inhalation and Nasal Drug Delivery Devices Revenue Growth 2019-2024 ($ millions) Figure 78. Manufacturing Cost Structure Analysis of Inhalation and Nasal Drug Delivery Devices in 2023 Figure 79. Manufacturing Process Analysis of Inhalation and Nasal Drug Delivery Devices Figure 80. Industry Chain Structure of Inhalation and Nasal Drug Delivery Devices Figure 81. Channels of Distribution Figure 82. Global Inhalation and Nasal Drug Delivery Devices Sales Market Forecast by Region (2025-2030) Figure 83. Global Inhalation and Nasal Drug Delivery Devices Revenue Market Share Forecast by Region (2025-2030) Figure 84. Global Inhalation and Nasal Drug Delivery Devices Sales Market Share Forecast by Type (2025-2030) Figure 85. Global Inhalation and Nasal Drug Delivery Devices Revenue Market Share Forecast by Type (2025-2030) Figure 86. Global Inhalation and Nasal Drug Delivery Devices Sales Market Share Forecast by Application (2025-2030) Figure 87. Global Inhalation and Nasal Drug Delivery Devices Revenue Market Share Forecast by Application (2025-2030)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GlaxoSmithKline (GSK)|||AstraZeneca|||Boehringer Ingelheim|||Viatris|||Merck|||Novartis|||AptarGroup|||Chiesi Farmaceutici|||Koninklijke Philips|||Teva Pharmaceutical Industries|||Monaghan Medical|||OMRON|||PARI International|||Vectura|||H&T Presspart|||LP Information|||Inc. (LPI)